Therma Bright (TSE:THRM) has released an update.
Therma Bright Inc. is gaining attention with its AI-Powered Digital Cough Technology, which is currently being considered for use in a U.S. clinical trial for a new chronic cough drug. The company is also working towards FDA classification and potential CMS reimbursement for the technology, aiming to enhance clinical decision-making and respiratory health monitoring.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
